History
2010~
2016
  • Aug.
  • FutureChem was awarded the Prize of Ministry of Trade, Industry and Energy
  • Aug.
  • Futurechem received a grade of "A" for Technology
  • Jul.
  • FutureChem (FC) signed an exclusive contract with Nihon Medi-Physics (NMP) Business Support Co. Ltd. (affiliate of NMP) for the sales of chemical products developed by FC
  • Jun.
  • Phase 3 clinical study of [18F]FC119S for imaging of Alzheimer's disease finished.
  • May
  • FutureChem signed MOU agreement with Nanjing PET-Tracer Co. (China) for general agreement on business partnership.
2015
  • Sep.
  • US patent of Futurechem's PET tracer, [18F]FC119S, for imaging of Alzheimer's disease registered.
  • Aug.
  • FutureChem is listed on KONEX
  • Jul.
  • FutureChem signed the CMO (contract manufacturing organization) contract with KIRAMS for [18F]FP-CIT.
  • May
  • Opened a new head office at Sungsu-dong (Seoul)
  • Mar.
  • Mergered "S-medi"
2014
  • Nov.
  • FutureChem signed MOU agreement with Advanced Radiation Technology Institute under Korea Atomic Energy Research Institute (KAERI in Jungeup).
  • Sep.
  • Completed installation of manufacturing facility at Dong-a University Hospital
  • May
  • FutureChem (FC) signed agreement with Busan City, KiJangGun for moving FC's headquarter to Southeast Area of Radiation Medicine & Science Complex.
  • Mar.
  • FutureChem Signed the MOU agreement with Korea Institute of Radiological & Medical Sciences (KIRAMS) for commercial production of Radiopharmaceutical and R&D
  • Jan.
  • FutureChem Signed the MOU agreement with Dong-a University Hospita for commercial production of Radiopharmaceutical and R&D
2013
  • Oct.
  • Agreement for the commercialization of radiopharmaceuticals with Seoul national university hostpital, Seoul national university bundang hostpital and Boramae Medical center
  • Sep.
  • Labeling research center of FutureChem moved to Dong-a university (Busan)
2012
  • Dec.
  • Nonclinical (Karolinska institute, Sweden) & Pre-clinical (Korea) studies of [18F]FC119S PET tracer, a diagnostic radiopharmaceutical for Alzheimer's disease, finished
2000~
2009
  • Sep.
  • Manufacturing of [18F]FLT and [18F]FP-CIT started in South Korea
2008
  • May.
  • Global 1st approval of [18F]FP-CIT for imaging of Parkinson's disease from KFDA
  • Apr.
  • Global 1st approval of [18F]FP-CIT for imaging of imaging of cancer from KFDA
2007
  • Dec.
  • FutureChem signed the license agreement with Bayer Schering Pharma AG for the technical transfer and mutual development of the [18F] PET tracer.
2005
  • Feb.
  • Labeling research center of FutureChem moved to Asan Medical Center
2003
  • Jun.
  • Obtained an official certificate as a R&D center annexed to FutureChem from Korea Industrial Technology Association - No. 20031586
  • Apr.
  • Joint research with department of nuclear medicine(Seoul national bundang hospital) and Korea Atomic Energy Research Institute (KAERI)
2002
  • Jan.
  • FutureChem signed the agreement with Dupon for the chemical synthesis.
2001
  • Aug.
  • Incorporated (a private corporation)
~1990
1999
  • Nov.
  • FutureChem established as a sole-proprietorship.